Skip to main content
. 2014 Jan 28;19(2):127–134. doi: 10.1634/theoncologist.2013-0359

Figure 2.

Figure 2.

Increase in patient preferences. (A): Increase in percentage of patients preferring treatment with a 5% reduction in each grade I/II side effect. (B): Increase in percentage of patients preferring treatment with a 5% reduction in each grade III/IV side effect.